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510a Tuesday, February 23, 2010[Ca2þ]r of triadin-null cells to levels similar to Wt cells, suggesting either an
additional Ca2þ entry pathway, insensitive Cd2þ and La3þ, or an enhanced
Ca2þ release. Inhibition of Ca2þ release by ryanodine resulted in a significant
reduction of [Ca2þ]r in triadin-null cells but not in Wt, indicating that triadin-
null cell also have increased baseline RyR1 channel activity. Western blot anal-
ysis and lipid bilayer studies revealed that calcium channels from triadin-null
cells have reduced FKBP-12 binding and increased subconductance states,
respectively. Accordingly, over expression of FKBP-12.6 caused a significant
reduction in [Ca2þ]r in triadin-nulls but did not affect Wt cells. Overall these
data support the idea that elevated resting free calcium levels observed in tria-
din-null myotubes are the combined effect of at least two things: (i) an increase
in calcium entry mediated by Cd2þ and La3þ sensitive channels, but insensitive
to nifedipine, and (ii) an augmented basal SR calcium release as the result of
enhanced RyR1 channel activity induced by a deficiency in RyR1/FKBP-12
binding.
Supported by NIH Grants 5K01AR054818-02 (to CFP) and 1P01AR044750 (to
PDA).
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The sarcolemmal L-type Ca2þ channel (DHPR), is known to both positively
and negatively regulate RyR1 in skeletal muscle. The mechanism for the neg-
ative control is unknown. To assess this we measured resting intracellular Ca2þ
concentration ([Ca2þ]rest) using Ca
2þ-selective microelectrodes in dysgenic
(MDG) and Wt myotubes. The [Ca2þ]rest in MDG and Wt myotubes were
1585 2.5 nM (mean5 SE, n ¼ 9) and 1175 2.1 nM (n ¼ 10), respectively
(p<0.001). Bastadin 5 (B5), which suppresses the leak state of RyR1, decreased
[Ca2þ]rest to 99 5 0.7 nM (n=16) and 10351.3 nM (n=16) in Wt and MDG
myotubes, respectively. After FK506 treatment, [Ca2þ]rest increased to 139
5 2.4 nM (n=10), 2175 3.0 nM (n=10) in Wt and MDG myotubes, respec-
tively and the addition of B5 in FK506 treated cells had negligible effect:
129 5 1.8 nM (n=10) and 202 5 3.5 nM (n=10) respectively. These experi-
ments clearly show that B5 treatment equalizes the [Ca2þ]rest in all the three
cell types tested while FK506 abolishes its action. To estimate the SR Ca2þ
content, we measured Ca2þ release elicited by 20 mM caffeine, using Fluo5N.
The area under the curve of the Fluo5N signal was ~4 times smaller in MDG
(2552.3 arbitrary units (a.u.), n=69) compared to Wt (10758.5 a.u, n=66)
and B5 increased the Ca2þ release only in MDG cells: 76516 a.u. (n=21)
MDG vs 101512 a.u. (n=60) Wt. These data demonstrate that the negative
control exerted by the DHPR is at least in part due to the ability of the
DHPR to control the percent of RyR1s in the leak state. Supported by NIH/
NIAMS R01AR43140 (to PDA and INP)
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Increased Sensitivity of RyR2 to Activation by Ca2þ and cADP-Ribose
during Diabetes
Chengju Tian, Chun-Hong Shao, Keshore Bidasee.
University of Nebraska Medical Center, Omaha, NE, USA.
In prior studies others and we found an increase in spontaneous Ca2þ release in
ventricular myocytes isolated from streptozotocin-induced diabetic rat hearts.
To date, molecular mechanisms underlying this phenomenon remains poorly
defined. This study tests the hypothesis that the sensitivity of RyR2 to be acti-
vated by intrinsic modulators is altered during diabetes. Diabetes was induced
in male Sprague-Dawley rats using streptozotocin. Ten weeks after injection,
diabetic rats were divided into two groups: one group was treated with insulin
for two weeks while the other group received no treatment. At the end of this
time, cardiac and myocyte functions were assessed using echocardiography and
high-speed video edge detection. Evoked Ca2þ transients were also assessed
using confocal microscopy. Expression of RyR2 was assessed using RT-PCR
and Western blots, while RyR2 activity and responsiveness to Ca2þ, cADP-ri-
bose and AMP-PCP were assessed using [3H]ryanodine binding and single
channel analyses. After 12 weeks of diabetes, ejection fraction and fraction
shortening were reduced by >25%. Rate of evoked Ca2þ release was slowed
as was the time to peak myocyte contraction. Expression of RyR2 and the total
amount of [3H]ryanodine bound at 200mM Ca2þ were reduced by z 40%.
However, the Kd for ryanodine remained essentially unchanged (5.2nM). Inter-
estingly, in [3H]ryanodine binding and single channel assays, diabetic RyR2was activated to a greater extentby low Ca2þ (0.53 mM and 1 mM), AMP-PCP
(1mM) and cADP-ribose (1 mM). Two-weeks of insulin, initiated after 10
weeks of diabetes, treatment blunted these changes. These new data indicate
that the increase in spontaneous Ca2þ release seen in diabetic myocytes stems
in part from alterations in the responsiveness of RyR2 to activation by intrinsic
ligands. Funded in part by NIH HL085061 and the Nebraska Redox Biology
Center.
2643-Pos
Effects of Divalent Current Carriers on Voltage-Dependence of RyR2
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Voltage-dependent modulation of cardiac ryanodine receptors (RyR2) was
studied in planar lipid bilayers. Different earth alkaline cations (M2þ: Mg2þ,
Ca2þ, Sr2þ, Ba2þ) were utilized as current carriers. When added to the cytosolic
surface of the channels, Ca2þ (EC50 ~2mM) or Sr
2þ (EC50 ~20mM) interacted
with cytosolic high affinity (HA) sites and activated the channels. Neither
Mg2þ nor Ba2þ activated RyR2 but only Mg2þ interfered with Ca2þ/Sr2þ ac-
tion. Fully activated RyR2 (100-200mM cytosolic Ca2þ) were inhibited with
low affinity (LA) by all M2þ (similar IC50, ranging 3.6-5.7mM) suggesting
that LA inhibitory sites do not distinguish M2þ identity. We found that
RyR2 were much more active with lumenal Ca2þ/Sr2þ versus lumenal Ba2þ/
Mg2þ. However increasing lumenal/cytosolic M2þ flux by increasing lu-
menal holding voltage (Vm) never increased open probability (Po). In contrast,
increasing Vm decreased Po in half of the RyR2 exposed to lumenal Ca2þ/Sr2þ
and in all RyR2 exposed to lumenal Ba2þ/Mg2. This suggests that lumenal flux
does not reach HA but LA sites. An effect of Vm is evident in all channels dis-
playing modal gating (low and high Po mode) but not in RyR2 where high Po
dominates. Indeed, high Po mode is much more abundant with lumenal Ca2þ/
Sr2þ. Moreover, increasing cytosolic Ca2þ activated all channels and removed
the effect of Vm. In summary, modulation of RyR2 gating by M2þ flux is com-
plex and seems to reflect lumenal M2þ-dependent stabilization of high Po and
low Po mode (the latter being voltage-dependent). Supported by NIH R01
GM078665 to JAC.
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Molecular Cloning and Expression of the Ryanodine Receptor Type 2
(RyR2) from Rat Cerebral Artery Smooth Muscle
Aditya K. Singh, Jianxi Liu, Alejandro M. Dopico.
University of Tennessee HSC, Memphis, TN, USA.
Ryanodine receptors (RyRs) are a family of Ca2þ release channels found in
intracellular Ca2þ storage/release organelles and participate in a variety of
important Ca2þ signaling phenomena. Here, we set to clone and sequence
full-length cDNA encoding the type 2 RyR (RyR2) from smooth muscle cells
of Rattus norvegicus cerebral arteries. Middle cerebral and basilar arteries
were isolated and de-endothelized, and total RNA was purified for RT-PCR.
RyR2 cDNA was divided in two parts of similar size; 5’ segment: 1-7486
bp, and 3’ segment: 7487-14862 bp. Specific primers were designed to obtain
both 5’ and 3’-terminals. Following insertion of both terminals in the mamma-
lian expression vector pCI-neo, we characterized several clones by restriction
analysis, and confirmed the full-length cDNA sequence by automated se-
quencing. The rat cerebral artery smooth muscle RyR2 cDNA contains
14862 bp and encodes a deduced protein of 4953 amino acids with a Mr of
562451.3 Da. Nucleotide blast analysis indicates that the cerebral artery
smooth muscle RyR2 shows 100% identity with recombinant RyR2 cloned
from rat cardiac muscle (Accession NM_032078). RyR2 cDNA expression
was determined after transfection of HEK293 cells with the insert into the
pCMV6-AN-tagGFP vector. Membrane insertion of cerebral artery myocyte
RyR2 was determined by immunolabeling with polyclonal antibodies. To
our knowledge, this is the first time that a RyR is cloned from rat cerebral
artery smooth muscle, its functional characteristics being currently studied.
Supported by Grant AA11560 (AMD).
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Bacterial Expression of the Ryanodine Receptor Pore Forming Region and
a Potassium Channel Chimera
Joanne Carney, Leon G. D’Cruz, Alan J. Williams.
Cardiff University, Cardiff, United Kingdom.
Several lines of evidence exist to support the proposal that RyR2 contains
a pore composed of structural elements analogous to the pore forming regions
(PFR) of Kþ channels. Our analogy model, constructed using the bacterial
Tuesday, February 23, 2010 511apotassium channel KcsA as the template, encompasses transmembrane helices
8-10 and provides an excellent description for the pore domain of RyR2 with
the overall structure and arrangement of key structural elements of the model
closely resembling those of KcsA (Biophysical Journal 2004, 87, 2335-2351).
Although good progress has been made in understanding ion handling capabil-
ities in RyR2 the exact mechanisms remain elusive and controversial. To test
and define the analogy model we have constructed and expressed both the
PFR of RyR2 alone and a KcsA_RyR2_PFR chimera whereby the 22 residue
N-terminal helix and 41 residue C-terminal domain of KcsA have been added
by primer extension to the RyR2 PFR region and cloned into a modified pET
expression vector containing an N-terminal hexa-His tag. Just as voltage sensor
modules are transferable among potassium channels, our chimera will give us
information on the functionality and transferability of the RyR2 PFR. Prelim-
inary results indicate that both the chimera and PFR constructs express in large
amounts in rosetta bacterial cells and are targeted to the membrane with no de-
tectable protein in the soluble fraction. Detergent trials have identified LDAO
as the best candidate for solubilisation from the membrane although other com-
monly used detergents are also capable of solubilisation, albeit to a lesser de-
gree. Both constructs were purified as tetramers following nickel-affinity and
gel filtration chromatography. This suggests strongly that both the RyR2
PFR and chimera are functional proteins capable of tetramerisation.
Supported by the British Heart Foundation.
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Malignant hyperthermia (MH) is a life-threatening pharmacogenetic syndrome
of skeletal muscle associated with mutations in the Ca2þ release channel - rya-
nodine receptor type 1 (RyR1). A genetically engineered knock-in mouse that
expresses the human C-terminal MH mutation T4826I RyR1 was created. Both
RyR1-T4826I/WT (HET) and RyR1-T4826I/T4826I (HOM) mice survive and
thrive if unchallenged with triggering agents. Sarcoplasmic reticulum mem-
branes from HET, HOM, and wild type (WT) mice were prepared to study
the biochemical and biophysical properties of RyR1complexes using [3H]rya-
nodine ([3H]Ry) binding analysis, western blotting, and single channels incor-
porated in bilayer lipid membranes. The results from this study reveal: (1) Sig-
nificantly elevated [3H]Ry binding in the preparations with rank order HOM
>>HET>WT), (2) significant diminution in the inhibitory potency of Ca2þ
and Mg2þ for both HOM and HET, (3) initial rates of [3H]Ry binding with
rank order HOM>>HET>WTwhen measured at either 25 C or 37C, (4) Sig-
nificantly greater open probability, longer mean open dwelling time and shorter
mean closed times with HOM and HET channels. These data indicate that the
T4826I RyR1 mutation confers significantly destabilizes the closed channel
conformation of RyR1, and the altered channel properties may be mostly re-
sponsible for the abnormal intracellular Ca2þ homeostasis and the MH suscep-
tibility. (Words: 202).
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AICAR Prevents Heat-Induced Death in Mice with Malignant Hyper-
thermia
Johanna T. Lanner, Cheng Long, JianJun Xu, Mariah R. Baker,
Susan L. Hamilton.
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The pharmacogenetic disorder malignant hyperthermia (MH) is serious and po-
tentially life-threatening illness caused by mutations in the skeletal muscle
Ca2þ-release channel (ryanodine receptor, RyR1) located in the membrane of
the sarcoplasmic reticulum. An MH episode is triggered by general anesthetics,
heat and exercise in warm conditions. Signs of an MH crisis are: elevated core
temperature, arrhythmias, hyper-metabolism and rhabdomyolysis. The MH
mice created in our laboratory with a Y524Sþ/- mutation in RyR1
(RyR1Y524Sþ/-) die upon exposure to elevated environmental temperatures
(37C) (Chelu et al 2006). The muscle relaxant dantrolene is the only known
treatment for an MH crisis, but its adverse side-effects preclude prophylactic
usage. We find that the treatment of the RyR1Y524Sþ/- mice with 5-aminoimi-
dazole-4-carboxamide ribonucleoside (AICAR), an activator of AMP-activated
protein kinase (AMPK), prevents heat-induced sudden death. Less than 5% of
untreated RyR1Y524Sþ/- mice survive a heat-challenge, but treatment with AI-
CAR leads to 100% survival. Muscle AMPK phosphorylation (AMPKaThr172)
levels are not significantly altered after 10 min subcutaneous injection with AI-
CAR compared to saline. This suggests that the rescue may not be due solely toAMPK activation, but may also involve off-target effect(s) of AICAR. Adenine
nucleotides are known channel agonists and AICAR is a precursor of the AMP
analog, ZMP. We tested the effects of AICAR on 3H -ryanodine binding in the
presence of non-hydrolysable ATP (AMP-PCP). We find that AICAR is a par-
tial agonist of RyR1 and prevents full activation of RyR1 in the presence of cel-
lular concentrations of ATP in both RyR1Y524Sþ/- and wild-type mice. AICAR
prevents heat-induced death in mice with MH and, since it is thought to have
few side-effects, it is a potential prophylactic treatment for heat induced death
associated with some MH mutations.
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Effects of a Y522S-RyR1 Mutation on Cerebellar Purkinje Cell Function
Jason A. Santiago, George C. Talbott, Nancy M. Lorenzon.
University of Denver, Denver, CO, USA.
The devastating consequences of calcium dysregulation are exemplified by
the skeletal muscle diseases malignant hyperthermia (MH) and central core
disease (CCD). These diseases result from mutations in the ‘skeletal muscle-
isoform’ of the ryanodine receptor calcium release channel (RyR1). To inves-
tigate the etiology of MH and CCD, mouse models have recently been
generated (Chelu et al. 2005). Skeletal muscle harboring the Y522S-RyR1
knock-in mutation exhibit Ca2þ leak from internal stores, basal cellular stress,
and ultimately progressive mitochondrial and cellular damage (Durham et al.
2008). Although the effects of this MH-causing mutation have been character-
ized in skeletal muscle, the effects in the nervous system have not been
documented. RyR1 is expressed highly in cerebellar Purkinje neurons.
Y522S-RyR1 mice do not exhibit gross neurological defects suggesting that
the defects may be subtle or that neuronal function is spared due to compen-
satory changes.
We have initiated studies investigating 3 main aspects of Y522S-RyR1 mouse
Purkinje cells: intracellular calcium release, cellular organization/morphology,
and cellular stress. In preliminary studies using imaging techniques with the
calcium indicator dye Fura2-AM, RyR-mediated calcium release in Y522S-
RyR1 Purkinje neurons exhibited a negative shift in the apparent EC50 for
the agonist caffeine. In addition, the sensitivity of RyR to other activators (tem-
perature, voltage, ryanodine) and intracellular calcium store content were in-
vestigated. Since calcium signaling is important during neuronal development
and maturation, the morphology of Y522S-RyR1 Purkinje cells was examined
using immunohistochemistry and confocal microscopy. Moreover, we have ini-
tiated studies to determine if altered RyR1 function results in basal cellular
stress using Western blot and immunohistochemical analyses. Y522S-RyR1
mutant mice provide an excellent tool to address calcium dysregulation, its
pathological consequences, and potential approaches for compensation of al-
tered calcium signaling in the central nervous system.
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Distinct Properties of CPVT Mutations Located in the Central Domain of
Human RyR2
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The cardiac ryanodine receptor (RyR2) Ca2þ release channel plays a central
role in the rapid calcium release from the sarcoplasmic reticulum that is essen-
tial for muscle excitation-contraction coupling. Discrete mutations that have
been discovered within the RyR2 associated with catecholaminergic polymor-
phic ventricular tachycardia (CPVT) are found to cluster in distinct regions of
RyR2. These regions may represent important regulatory domains of the mol-
ecule that either directly or indirectly can affect channel gating. In response to
a physiological trigger, RyR2 mutations are believed to cause diastolic Ca2þ
leak which results in arrhythmia, making them an important potential therapeu-
tic target.
We have expressed the RyR2 central domain CPVT-associated region and ex-
amined parameters which contribute to the structural and functional stability. A
wild-type construct was compared with three constructs each containing a dif-
ferent CPVT mutation (P2328S, N2368I or A2387P). Circular dichroism spec-
troscopy revealed that none of the mutations significantly altered the percent-
age ellipticity of the protein, indicating that the overall conformation of the
polypeptide backbone is only slightly affected by the mutations. Chemical de-
naturation using guanidine hydrochloride and monitoring tryptophan fluores-
cence suggested that the P2328S mutation was less stable than the wild-type
or the other two mutations, indicated by a lower free energy change upon un-
folding. A predicted ATP binding motif has previously been proposed in this
domain and using fluorescence spectroscopy for the wild-type construct,
ATP binding was observed with a Kd ~0.03mM.
